article thumbnail

Drug Channels News Roundup, February 2021: Accumulator Problems, Humana + ESI, White Bagging Battles, Buy-and-Bill Economics, and Pharmacy Hero Dave Marley

Drug Channels

Approximately one out of four payers strongly agrees that accumulators could have the potential to discourage appropriate utilization of specialty therapies. For background, see Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal. The battle for specialty drug margin rages on.